CD8A and gastrointestinal stromal tumor: In correlation with this finding, IDO1 inhibitor increased CD8+ T cells and reduced tumor growth in a transgenic mouse model of cecal gastrointestinal stromal tumors, which was reversed by CD8+ T cell depletion (55).